FDA Releases Draft Guidance on Labeling of Nonprescription Human Drugs

Summary

The Food and Drug Administration (FDA) has published a draft guidance to help the pharmaceutical industry comply with labeling requirements for nonprescription human drugs marketed without FDA approval, as mandated by the Dietary Supplement and Nonprescription Drug Consumer Protection Act.